Avantor, Inc. (NYSE:AVTR) Receives $26.71 Consensus PT from Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have received an average recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $26.71.

A number of brokerages have recently issued reports on AVTR. Royal Bank of Canada upped their price target on Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Deutsche Bank Aktiengesellschaft increased their target price on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Thursday, April 18th. UBS Group increased their target price on Avantor from $25.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. JPMorgan Chase & Co. increased their target price on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Finally, Robert W. Baird increased their target price on Avantor from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Thursday, February 15th.

Insiders Place Their Bets

In other Avantor news, EVP James Bramwell sold 6,203 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at approximately $2,476,992.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in shares of Avantor by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 65,457,140 shares of the company’s stock valued at $1,379,837,000 after acquiring an additional 211,189 shares during the period. Boston Partners increased its holdings in shares of Avantor by 21.4% in the 3rd quarter. Boston Partners now owns 28,077,026 shares of the company’s stock valued at $588,362,000 after acquiring an additional 4,948,951 shares during the period. Artemis Investment Management LLP increased its holdings in shares of Avantor by 14.9% in the 1st quarter. Artemis Investment Management LLP now owns 9,120,083 shares of the company’s stock valued at $233,109,000 after acquiring an additional 1,180,937 shares during the period. Robeco Schweiz AG increased its holdings in shares of Avantor by 8.1% in the 3rd quarter. Robeco Schweiz AG now owns 8,154,000 shares of the company’s stock valued at $171,886,000 after acquiring an additional 607,500 shares during the period. Finally, Norges Bank purchased a new position in shares of Avantor in the 4th quarter valued at $156,455,000. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Trading Up 1.3 %

Shares of NYSE:AVTR opened at $24.41 on Friday. The company has a market cap of $16.55 billion, a P/E ratio of 50.84, a PEG ratio of 2.45 and a beta of 1.37. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05. Avantor has a 1 year low of $16.63 and a 1 year high of $26.16. The stock’s fifty day moving average price is $24.96 and its 200-day moving average price is $22.51.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.03. The firm had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The company’s quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.32 earnings per share. Sell-side analysts expect that Avantor will post 1.01 earnings per share for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.